Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

795.12 +2.82 (+0.36%)
Official Closing Price Updated: 7:00 PM EDT, Jun 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,118,314
Open 793.95
Bid (Size) 792.00 (1)
Ask (Size) 795.00 (1)
Prev. Close 792.30
Today's Range 788.25 - 798.80
52wk Range 677.09 - 972.53
Shares Outstanding N/A
Dividend Yield 0.75%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why This Weight Loss Drug Company's Stock Surged Today
Via The Motley Fool
3 Growth Stocks I'm Loading Up On
Via The Motley Fool
Topics Artificial Intelligence Government

Performance

YTD
+2.2%
+2.2%
1 Month
+9.6%
+9.6%
3 Month
-3.8%
-3.8%
6 Month
+0.1%
+0.1%
1 Year
-12.1%
-12.1%

More News

Read More
5 Revealing Analyst Questions From Eli Lilly’s Q1 Earnings Call
Via StockStory
Topics Earnings World Trade
Why Shares in Novo Nordisk Lost Weight Today
Via The Motley Fool
US Adults Struggle With Long-Term Use Of Obesity Drugs Like Wegovy, Data Shows
Via Benzinga
Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity
Via Investor's Business Daily
What's Going On With Viking Therapeutics Stock On Wednesday?
Via Benzinga
Which S&P500 stocks are moving on Wednesday?
Via Chartmill
Tesla's Robotaxi Rollout
Via The Motley Fool
Topics Stocks
7 Space Stocks I'd Buy Without Hesitation
Via The Motley Fool
Topics Artificial Intelligence Economy
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
Via The Motley Fool
Topics Government World Trade
Eli Lilly’s Newest Obesity Drug Candidate Stirs Wall Street Buzz, But Not Everyone’s Sold
Via Stocktwits
Novo's India Move Could Reshape The Weight-Loss Drug War With Eli Lilly
Via Benzinga
New AI Rollouts Signal Shift From Hype to Healthcare Reality
Via FinancialNewsMedia
Topics Artificial Intelligence
Hims & Hers CEO Hits Back At Novo Nordisk After Abrupt End Of Collaboration, Alleges Wegovy-Maker Is ‘Misleading The Public’
Via Stocktwits
Amgen Expands Development Plans For Highly Anticipated Obesity Drug
Via Investor's Business Daily
Why Novo Nordisk Stock Is Sinking Today
Via The Motley Fool
Topics Stocks Supply Chain
IWF Is a Great Choice for Most, But I Like VUG ETF Better
Via The Motley Fool
Topics ETFs
Novo Nordisk's Weight Loss Injection CagriSema Data Sparks Investor Concern
Via Benzinga
Eli Lilly's Investigational Oral Pill Shows Weight Loss Benefits With Lingering Side Effect Concerns
Via Benzinga
Watch Out, Novo Nordisk & Eli Lilly: Chinese Biotech Steps Into the Ring To Take On Global Weight-Loss Leaders
Via Stocktwits
Eli Lilly Hits Dual Wins: Orforglipron, Efsitora Meet Phase 3 Goals For Blood Sugar, Weight Loss And Diabetes Care
Via Stocktwits
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
Via The Motley Fool
Obesity Drugs Help With Weight Loss But Are Adding Fat Elsewhere
Via Benzinga
Uncover the latest developments among S&P500 stocks in today's session.
Via Chartmill

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 795.12
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 06/26/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.